This volume investigates the primary clinical advancements and research findings in the field of dyslipidaemia during the year 2003. The author, a recognized expert in lipid metabolism, synthesizes complex clinical data and pharmacological studies to provide a comprehensive overview of lipid-lowering therapies and cardiovascular risk management. The text serves as a critical update for practitioners, evaluating the efficacy of emerging treatments and the shifting paradigms in cholesterol management during that specific period.

Medical professionals and researchers frequently cite this work as a valuable historical snapshot of clinical standards in early 21st-century cardiology. Experts highlight the text for its technical precision and its utility in tracking the evolution of lipid management protocols.